WallStreetZen

AnalystsAndrew D'Silva
Andrew D'Silva's Stock Forecasts

Ranking
Top 3%
#87 out of 3514 analysts
Average Return
+71.19%
Win Rate
63%17 out of 27
Risk vs Reward
Poor
Good

Andrew D'Silva's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
OptimizeRx CorpOPRX
+468.59%$8.50$48.33
2020-04-07 -
2021-04-07
Strong Buy
CorMedix IncCRMD
+308.09%$2.35$9.59
2020-03-18 -
2021-03-18
Strong Buy
Edap Tms SaEDAP
+305.83%$2.23$9.05
2020-04-15 -
2021-04-15
Strong Buy
Cryoport IncCYRX
+212.88%$16.38$51.25
2020-04-07 -
2021-04-07
Strong Buy
Verso CorpVRS
+201.98%$6.07$18.33
2017-04-28 -
2018-04-27
Strong Buy

Andrew D'Silva's Stock Coverage

Name / Ticker# of RatingsRatingPrice TargetUpside/DownsideActionDate
1Strong Buy$9.00N/AInitiates Coverage On
2 months ago
MultiPlan CorpMPLN
1Strong Buy$10.00-19.50%Initiates Coverage On
4 months ago
Cryoport IncCYRX
2Strong Buy$81.00-23.80%Maintains
6 months ago
ViewRay IncVRAY
3Strong BuyN/AN/AUpgrades
9 months ago
Edap Tms SaEDAP
1Strong Buy$5.50N/AInitiates Coverage On
a year ago
OptimizeRx CorpOPRX
1Strong Buy$18.00N/AMaintains
a year ago
Intricon CorpIIN
6Strong Buy$26.50N/AMaintains
a year ago
Harrow Health IncHROW
2Strong Buy$10.00N/AMaintains
a year ago
Alimera Sciences IncALIM
1Strong Buy$15.00N/AMaintains
a year ago
EyePoint Pharmaceuticals IncEYPT
1Hold$1.00N/ADowngrades
a year ago
CorMedix IncCRMD
2Strong Buy$10.00N/AMaintains
a year ago
Geron CorpGERN
1Strong Buy$3.50N/AMaintains
a year ago
Verso CorpVRS
4Hold$26.00N/ADowngrades
2 years ago
Unique Fabricating IncUFAB
1Strong Buy$9.00N/AMaintains
3 years ago
Adamis Pharmaceuticals CorpADMP
1Hold$2.50N/ADowngrades
3 years ago
Osi Systems IncOSIS
2Strong Buy$92.50N/AMaintains
3 years ago
Cumberland Pharmaceuticals IncCPIX
1Strong Buy$8.75N/AMaintains
3 years ago
Oramed Pharmaceuticals IncORMP
1Strong Buy$20.00N/AReinstates
4 years ago
1Strong Buy$12.00N/AMaintains
4 years ago
1HoldN/AN/ADowngrades
4 years ago
1Strong Buy$7.75N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.